ProMIS Neurosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.61-0.50-1.641.04
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-0.92$-1.12$-0.34$0.54

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-12.82-3.90-8.87-8.65-8.74-7.73-6.56-4.99-2.55-0.80-1.94-8.74
Price/Sales ratio
194.79415.7211.40K5.26K187.19K47.62K20.79K5.93KN/AN/A9.22K47.62K
Price/Book Value ratio
-131.859.95328.7327.0156.45110.07-28.686.74-17.842.84-28.33110.07
Price/Cash Flow ratio
-16.06-5.26-12.06-9.13-10.28-9.40-8.53-5.19-1.91-0.98-2.00-10.28
Price/Free Cash Flow ratio
-16.06-5.26-12.06-9.13-10.28-9.40-8.32-5.19-1.91-0.98-2.00-10.28
Price/Earnings Growth ratio
0.990.06-1.25-0.16-0.260.250.22-0.06-1.420.040.02-0.26
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%-514509.19%-227041.81%-71796.87%N/AN/AN/AN/A
Operating Profit Margin
-1519.23%-10519.48%-127799.59%-60766.72%-2140431.57%-615329.36%-316865.80%-101363.57%N/AN/A-649766.82%-2140431.57%
Pretax Profit Margin
-1519.23%-10639.79%-128390.00%-60838.50%-2140431.57%-615329.36%-316865.80%-113562.83%N/AN/A-473610.94%-2140431.57%
Net Profit Margin
-1519.23%-10639.79%-128390.00%-60838.50%-2140431.57%-615329.36%-316865.80%-118662.24%N/AN/A-473610.94%-2140431.57%
Effective Tax Rate
N/A-1.13%-0.45%-0.11%2.09%N/AN/A-4.49%29.44%0.95%N/AN/A
Return on Assets
-692.09%-132.81%-265.59%-220.52%-251.67%-273.05%-320.64%-43.03%-135.93%-97.01%-283.12%-273.05%
Return On Equity
1028.35%-254.74%-3702.09%-312.20%-645.58%-1422.21%437.09%-134.93%698.40%-352.02%-655.93%-1422.21%
Return on Capital Employed
1028.35%-251.86%-3685.06%-311.83%-645.58%-1422.21%437.09%-38.79%-3375.26%-334.06%-5257.52%-1422.21%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.07N/A
Quick Ratio
0.412.041.033.361.621.240.5219.101.081.450.921.24
Cash ratio
0.051.630.792.651.320.990.4218.230.911.340.910.99
Days of Sales Outstanding
1.75N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A-4.37-3.55-3.03-1.20N/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A-4.37-3.55-3.03N/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/A27.4350.1625.5149.86363.14N/A27.43
Cash Conversion Cycle
N/AN/AN/AN/AN/A-31.81-53.72-28.54N/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A0.100.09N/AN/AN/AN/A0.22N/AN/A1.19N/A
Debt Equity Ratio
N/A0.191.29N/AN/AN/AN/A0.69N/AN/A-6.13N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.40N/AN/AN/AN/A
Total Debt to Capitalization
N/A0.160.56N/AN/AN/AN/A0.40N/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-92.83N/A
Cash Flow to Debt Ratio
N/A-9.58-21.04N/AN/AN/AN/A-1.87N/AN/AN/AN/A
Company Equity Multiplier
-1.481.9113.931.412.565.20-1.363.13-5.133.62-5.135.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-12.12-78.92-945.30-575.98-18.19K-5.06K-2.43K-1.14KN/AN/A-4.59K-18.19K
Free Cash Flow / Operating Cash Flow Ratio
1111111.021.001.0011.001
Cash Flow Coverage Ratio
N/A-9.58-21.04N/AN/AN/AN/A-1.87N/AN/AN/AN/A
Short Term Coverage Ratio
N/A-9.58-21.04N/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A